2125 related articles for article (PubMed ID: 8586465)
1. Neurofibromatosis type 2 and von Hippel-Lindau disease: from gene cloning to function.
Kley N; Whaley J; Seizinger BR
Glia; 1995 Nov; 15(3):297-307. PubMed ID: 8586465
[TBL] [Abstract][Full Text] [Related]
2. The neurofibromatosis 2 (NF2) tumour suppressor gene: implications beyond the hereditary tumour syndrome?
Kley N; Seizinger BR
Cancer Surv; 1995; 25():207-18. PubMed ID: 8718520
[TBL] [Abstract][Full Text] [Related]
3. [Neurofibromatosis type 2 (NF2)].
Araki N; Takeshima H; Saya H
Gan To Kagaku Ryoho; 1997 Sep; 24(11):1427-31. PubMed ID: 9309136
[TBL] [Abstract][Full Text] [Related]
4. NF2: the wizardry of merlin.
Xiao GH; Chernoff J; Testa JR
Genes Chromosomes Cancer; 2003 Dec; 38(4):389-99. PubMed ID: 14566860
[TBL] [Abstract][Full Text] [Related]
5. Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas.
Kanno H; Kondo K; Ito S; Yamamoto I; Fujii S; Torigoe S; Sakai N; Hosaka M; Shuin T; Yao M
Cancer Res; 1994 Sep; 54(18):4845-7. PubMed ID: 8069849
[TBL] [Abstract][Full Text] [Related]
6. Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype.
Chen F; Kishida T; Yao M; Hustad T; Glavac D; Dean M; Gnarra JR; Orcutt ML; Duh FM; Glenn G
Hum Mutat; 1995; 5(1):66-75. PubMed ID: 7728151
[TBL] [Abstract][Full Text] [Related]
7. Genetics of renal-cell carcinoma and evidence for a critical role for von Hippel-Lindau in renal tumorigenesis.
Gnarra JR; Lerman MI; Zbar B; Linehan WM
Semin Oncol; 1995 Feb; 22(1):3-8. PubMed ID: 7855617
[TBL] [Abstract][Full Text] [Related]
8. [Does hemangioblastoma exist outside von Hippel-Lindau disease?].
Richard S; Beigelman C; Gerber S; Van Effenterre R; Gaudric A; Sahel M; Binaghi M; De Kersaint-Gilly A; Houtteville JP; Brunon JP
Neurochirurgie; 1994; 40(3):145-54. PubMed ID: 7723921
[TBL] [Abstract][Full Text] [Related]
9. [Von Hippel-Lindau disease and central nervous system hemangioblastoma. Progress in genetics and clinical management].
Richard S; Martin S; David P; Decq P
Neurochirurgie; 1998 Nov; 44(4):258-66. PubMed ID: 9864697
[TBL] [Abstract][Full Text] [Related]
10. Detection of von Hippel-Lindau disease gene mutations in paraffin-embedded sporadic renal cell carcinoma specimens.
Zhuang Z; Gnarra JR; Dudley CF; Zbar B; Linehan WM; Lubensky IA
Mod Pathol; 1996 Aug; 9(8):838-42. PubMed ID: 8871925
[TBL] [Abstract][Full Text] [Related]
11. von Hippel-Lindau disease: recent advances and therapeutic perspectives.
Richard S;
Expert Rev Anticancer Ther; 2003 Apr; 3(2):215-33. PubMed ID: 12722881
[TBL] [Abstract][Full Text] [Related]
12. Multifocal bilateral renal cell carcinoma and retinal angiomas in a patient with de novo von Hippel-Lindau disease: identification of a new germline mutation.
Sessa A; Battini G; Meroni M; Pitingolo F; Righetti M; Ciotti P; Di Maria E; Bellone E; Ajmar F; Mandich P
J Nephrol; 2005; 18(2):209-12. PubMed ID: 15931650
[TBL] [Abstract][Full Text] [Related]
13. [Molecular biological analysis of neurofibromatosis type 2 gene].
Ichimura K; Yuasa Y
Nihon Rinsho; 1993 Sep; 51(9):2462-6. PubMed ID: 8411729
[TBL] [Abstract][Full Text] [Related]
14. [From gene to disease; Von Hippel-Lindau disease].
Hes FJ; Los M; van der Luijt RB
Ned Tijdschr Geneeskd; 2002 Jul; 146(29):1364-7. PubMed ID: 12162174
[TBL] [Abstract][Full Text] [Related]
15. Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel-Lindau tumor suppressor-binding protein (CUL2 and VBP1) mutation and loss in renal-cell carcinoma development.
Clifford SC; Walsh S; Hewson K; Green EK; Brinke A; Green PM; Gianelli F; Eng C; Maher ER
Genes Chromosomes Cancer; 1999 Sep; 26(1):20-8. PubMed ID: 10441001
[TBL] [Abstract][Full Text] [Related]
16. Molecular genetic studies of sporadic and familial renal cell carcinoma.
Gnarra JR; Glenn GM; Latif F; Anglard P; Lerman MI; Zbar B; Linehan WM
Urol Clin North Am; 1993 May; 20(2):207-16. PubMed ID: 8098558
[TBL] [Abstract][Full Text] [Related]
17. Constitutional von Hippel-Lindau (VHL) gene deletions detected in VHL families by fluorescence in situ hybridization.
Pack SD; Zbar B; Pak E; Ault DO; Humphrey JS; Pham T; Hurley K; Weil RJ; Park WS; Kuzmin I; Stolle C; Glenn G; Liotta LA; Lerman MI; Klausner RD; Linehan WM; Zhuang Z
Cancer Res; 1999 Nov; 59(21):5560-4. PubMed ID: 10554035
[TBL] [Abstract][Full Text] [Related]
18. Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease.
Phillips JL; Ghadimi BM; Wangsa D; Padilla-Nash H; Worrell R; Hewitt S; Walther M; Linehan WM; Klausner RD; Ried T
Genes Chromosomes Cancer; 2001 May; 31(1):1-9. PubMed ID: 11284029
[TBL] [Abstract][Full Text] [Related]
19. Juvenile renal cell carcinoma as first manifestation of von Hippel-Lindau disease.
Granata A; Sessa A; Righetti M; Cordaro S; Leone G; Figura M; Fatuzzo P; Rapisarda F; Di Maria E; Ciotti P; Mandich P; Nardo A; Ferrone M; Gallone S; Liuzzo G
J Nephrol; 2004; 17(2):306-10. PubMed ID: 15293534
[TBL] [Abstract][Full Text] [Related]
20. Mutations of the VHL tumour suppressor gene in renal carcinoma.
Gnarra JR; Tory K; Weng Y; Schmidt L; Wei MH; Li H; Latif F; Liu S; Chen F; Duh FM
Nat Genet; 1994 May; 7(1):85-90. PubMed ID: 7915601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
